Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT02289898 · COMPLETED
Trial details
- NCT number
- NCT02289898
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-20
- Primary completion
- 2017-05-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.